Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. 1994

C Desprat, and J M Zajac
Laboratoire de Pharmacologie et de Toxicologie Fondamentales, CNRS, Toulouse, France.

The postnatal ontogeny of neuropeptide FF (NPFF) receptors in mouse brain was mapped by quantitative autoradiography using [125I](1DME)Y8Famide as selective radioligand. By day 14, the adult distribution of NPFF sites was established in almost all brain areas. The density of NPFF receptors reached adult levels between 14 and 28 days after birth, earlier than did mu or delta opioid receptors. During ontogeny, morphine analgesia was measured in hindpaw, forepaw and tail immersion tests (57 degrees C). An antinociceptive effect of morphine in the forepaw and tail immersion test was evident in 14-day-old but not in 7-day-old mice. In 14 and 21 day-old mice, the influence of (1DME)Y8Famide on morphine analgesia depended on the dose and on the particular test. A low dose of (1DME)Y8Famide inhibited morphine analgesia in the tail or hindpaw test, whereas a higher dose had either no effect (tail test) or increased morphine activity (hindpaw test). In adult mice, only the inhibition of morphine antinociception by (1DME)Y8Famide was observed. These observations revealed the establishment of an equilibrium between NPFF and opioid functions during ontogeny.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral

Related Publications

C Desprat, and J M Zajac
October 1993, The Journal of pharmacology and experimental therapeutics,
C Desprat, and J M Zajac
January 2011, ACS medicinal chemistry letters,
C Desprat, and J M Zajac
November 2020, Journal of medicinal chemistry,
C Desprat, and J M Zajac
July 2010, The Journal of pharmacology and experimental therapeutics,
C Desprat, and J M Zajac
December 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!